Dovato

DOVATO (dolutegravir/lamivudine) is listed on the Australian Register of Therapeutic Goods (ARTG).

DOVATO is indicated for the treatment of HIV-1 infection in antiretroviral treatment-naïve adults and adolescents (from 12 years of age weighing at least 40 kg) who have no known or suspected resistance to either antiretroviral component.

PBS Information: This product is listed on the PBS as a section 100 item. Refer to PBS schedule for full authority information.

Resources

For patients:

• Dovato Consumer Medicine Information (PDF)

For HCPs:

• Dovato Product Information (PDF)